Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Erasca, Inc.(ERAS) | 9,273,428 | 12,151,480 | +2,878,052 | $34.50M | $196.61M | 16.34% | +$162.11M |
| Praxis Precision Medicines, Inc.(PRAX) | 328,895 | 338,895 | +10,000 | $96.94M | $109.19M | 9.08% | +$12.25M |
| Terns Pharmaceuticals Inc | 5,346,928 | 1,334,418 | -4,012,510 | $216.02M | $70.35M | 5.85% | -$145.67M |
| Trevi Therapeutics, Inc.(TRVI) | 5,094,668 | 5,094,668 | 0 | $63.79M | $60.78M | 5.05% | -$3.01M |
| DBV Technologies S.A.ADS(DBVT) | 2,461,626 | 2,667,569 | +205,943 | $47.19M | $55.73M | 4.63% | +$8.54M |
| Compass Therapeutics, Inc.(CMPX) | 9,545,466 | 9,545,466 | 0 | $51.26M | $50.50M | 4.20% | -$763.6K |
| Tango Therapeutics, Inc.(TNGX) | 2,154,780 | 2,154,780 | 0 | $19.09M | $45.08M | 3.75% | +$25.99M |
| SAB Biotherapeutics, Inc.(SABS) | 11,420,000 | 11,420,000 | 0 | $42.71M | $43.74M | 3.64% | +$1.03M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 2,234,566 | 2,805,816 | +571,250 | $17.21M | $41.05M | 3.41% | +$23.84M |
| Bright Minds Biosciences Inc.(DRUG) | 501,617 | 557,172 | +55,555 | $39.15M | $40.66M | 3.38% | +$1.51M |
| Sinovac Biotech, Ltd.SHS(SVA) | 5,903,000 | 5,903,000 | 0 | $38.19M | $38.19M | 3.17% | $0 |
| Dianthus Therapeutics, Inc.(DNTH) | 353,998 | 353,998 | 0 | $14.59M | $29.71M | 2.47% | +$15.12M |
| Dyne Therapeutics, Inc.(DYN) | 2,614,960 | 1,557,466 | -1,057,494 | $51.15M | $28.24M | 2.35% | -$22.91M |
| ABIVAX Société AnonymeADS(ABVX) | 359,305 | 239,539 | -119,766 | $48.45M | $26.67M | 2.22% | -$21.78M |
| Minerva Neurosciences, Inc.(NERV) | 4,322,747 | 4,322,747 | 0 | $17.38M | $26.04M | 2.17% | +$8.67M |
| Aclaris Therapeutics, Inc.(ACRS) | 8,888,888 | 6,666,666 | -2,222,222 | $26.76M | $25.00M | 2.08% | -$1.76M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 2,118,384 | 1,848,786 | -269,598 | $17.33M | $23.42M | 1.95% | +$6.10M |
| Alto Neuroscience, Inc.(ANRO) | 1,035,551 | 1,035,551 | 0 | $18.43M | $23.28M | 1.94% | +$4.85M |
| Faeth Therapeutics, Inc.(FTH) | 0 | 722,020 | +722,020 | $0 | $22.76M | 1.89% | +$22.76M |
| ArriVent BioPharma, Inc.(AVBP) | 0 | 885,916 | +885,916 | $0 | $20.44M | 1.70% | +$20.44M |
| LB Pharmaceuticals Inc(LBRX) | 800,000 | 800,000 | 0 | $17.81M | $19.73M | 1.64% | +$1.92M |
| Veradermics, Incorporated(MANE) | 0 | 300,000 | +300,000 | $0 | $18.95M | 1.57% | +$18.95M |
| CAMP4 THERAPEUTICS CORPORATION(CAMP) | 4,246,568 | 4,246,568 | 0 | $26.03M | $18.73M | 1.56% | -$7.30M |
| MoonLake Immunotherapeutics(MLTX) | 1,000,000 | 1,000,000 | 0 | $13.18M | $18.64M | 1.55% | +$5.46M |
| Design Therapeutics, Inc.(DSGN) | 1,612,903 | 1,612,903 | 0 | $15.13M | $17.16M | 1.43% | +$2.03M |
| Cogent Biosciences, Inc.(COGT) | 2,398,993 | 422,300 | -1,976,693 | $85.21M | $16.25M | 1.35% | -$68.96M |
| Geron Corporation(GERN) | 27,225,292 | 8,671,797 | -18,553,495 | $35.94M | $12.92M | 1.07% | -$23.02M |
| Unicycive Therapeutics, Inc.(UNCY) | 1,789,916 | 1,789,916 | 0 | $10.33M | $11.78M | 0.98% | +$1.45M |
| AN2 Therapeutics Inc | 0 | 3,153,640 | +3,153,640 | $0 | $10.79M | 0.90% | +$10.79M |
| Olema Pharmaceuticals, Inc.(OLMA) | 671,843 | 671,843 | 0 | $16.80M | $10.02M | 0.83% | -$6.78M |
| Soleno Therapeutics Inc | 894,909 | 294,909 | -600,000 | $41.43M | $9.87M | 0.82% | -$31.56M |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 1,350,000 | 1,350,000 | 0 | $10.19M | $9.77M | 0.81% | -$418.5K |
| OnKure Therapeutics, Inc.(OKUR) | 0 | 1,927,710 | +1,927,710 | $0 | $7.98M | 0.66% | +$7.98M |
| Surrozen, Inc.(SRZN) | 260,000 | 260,000 | 0 | $5.88M | $7.57M | 0.63% | +$1.70M |
| ALX Oncology Holdings Inc.(ALXO) | 0 | 3,184,713 | +3,184,713 | $0 | $6.39M | 0.53% | +$6.39M |
| Monopar Therapeutics Inc.(MNPR) | 90,500 | 90,500 | 0 | $5.91M | $4.96M | 0.41% | -$951.2K |
| Satellos Bioscience Inc.(MSLE) | 0 | 813,666 | +813,666 | $0 | $4.58M | 0.38% | +$4.58M |
| PepGen Inc.(PEPG) | 2,325,000 | 2,325,000 | 0 | $15.14M | $4.12M | 0.34% | -$11.02M |
| Sera Prognostics, Inc.(SERA) | 1,650,440 | 1,650,440 | 0 | $4.87M | $3.35M | 0.28% | -$1.52M |
| Tenax Therapeutics, Inc.(TENX) | 208,333 | 208,333 | 0 | $2.54M | $3.33M | 0.28% | +$791.7K |
| Viridian Therapeutics, Inc.(VRDN) | 982,576 | 166,288 | -816,288 | $30.58M | $3.25M | 0.27% | -$27.33M |
| Instil Bio, Inc.(TIL) | 292,743 | 292,743 | 0 | $3.22M | $2.41M | 0.20% | -$808.0K |
| Pasithea Therapeutics Corp.(KTTA) | 2,100,000 | 2,100,000 | 0 | $2.71M | $1.56M | 0.13% | -$1.15M |
| COMPASS Pathways plcADS(CMPS) | 0 | 200,000 | +200,000 | $0 | $1.11M | 0.09% | +$1.11M |
| Bolt Therapeutics Inc | 72,414 | 72,414 | 0 | $396.0K | $292.6K | 0.02% | -$103.4K |
| Precision BioSciences, Inc.(DTIL) | 4,675 | 4,675 | 0 | $19.4K | $25.7K | 0.00% | +$6.3K |
| Abeona Therapeutics Inc.(ABEO) | 1,842,751 | 0 | -1,842,751 | $9.71M | $0 | — | -$9.71M |
| Avadel Pharmaceuticals PLCADR | 2,684,109 | 0 | -2,684,109 | $57.84M | $0 | — | -$57.84M |
| Cidara Therapeutics, Inc. | 956,670 | 0 | -956,670 | $211.32M | $0 | — | -$211.32M |
| CytomX Therapeutics, Inc.(CTMX) | 2,884,615 | 0 | -2,884,615 | $12.29M | $0 | — | -$12.29M |
| EnGene Holdings IncWARRANTS *W EXP 10/31/202 | 285,046 | 0 | -285,046 | $843.7K | $0 | — | -$843.7K |
| Palisade Bio, Inc.(PALI) | 2,293,578 | 0 | -2,293,578 | $5.39M | $0 | — | -$5.39M |
| Silence Therapeutics plcADS(SLN) | 1,105,454 | 0 | -1,105,454 | $6.72M | $0 | — | -$6.72M |
| Verastem, Inc.(VSTM) | 1,106,524 | 0 | -1,106,524 | $8.54M | $0 | — | -$8.54M |
| Zenas BioPharma, Inc.(ZBIO) | 853,495 | 0 | -853,495 | $30.99M | $0 | — | -$30.99M |